At a glance

ClinicalIndex Comparison Record

Phase 4Completed

Drug / intervention

GlucoWatch® G2™ Biographer (GW2B) +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00069628

NCT00069628Phase 4Completed

Compare CT.gov

DirecNet Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer in the Management of Type 1 Diabetes in Children

Jaeb Center for Health Research·interventional·Posted Sep 30, 2003·Updated Sep 5, 2016

In Brief

A Phase 4 clinical trial evaluating GlucoWatch® G2™ Biographer (GW2B) and Continuous Glucose Monitoring System (CGMS) for Diabetes Mellitus, Insulin-Dependent. Completed, across 6 sites.

Detailed Summary

This study will evaluate the safety and effectiveness of a continuous glucose monitor in children with Type 1 diabetes mellitus (T1DM).

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDiabetes Mellitus, Insulin-Dependent

CountriesUnited States

CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 4CompletedFinished

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJul 2003

First PostedSep 2003

Study CompletionNov 2004

TodayJul 2026

First PostedSep 30, 2003

Enrollment StartJul 1, 2003

Study CompletionNov 1, 2004

TodayJul 2, 2026

Posted 22.8 years ago

Interventions

GlucoWatch® G2™ Biographer (GW2B)device

Continuous Glucose Monitoring System (CGMS)device